Can IVUS Define Plaque Features that Impact Patient Care?

Size: px
Start display at page:

Download "Can IVUS Define Plaque Features that Impact Patient Care?"

Transcription

1 Can IVUS Define Plaque Features that Impact Patient Care? A Pichard L Satler, K Kent, R Waksman, W Suddath, N Bernardo, N Weissman, M Angelo, D Harrington, J Lindsay, J Panza. Washington Hospital Center Washington DC

2 Conflict of Interest None related to this presentation

3 IVUS at the WHC Washington Hospital Center in last 12 months: Diagnostic catheterizations: 10,000 Coronary angioplasties: 5,000 IVUS use: 70% (AP: 95%) Organization 10 Labs: 8 Labs have IVUS integrated into the Cath Table (Volcano and Boston). IVUS setup is ready before physician arrives into the room. 2 CV technicians supervise all IVUS cases. 15 CV technicians trained in IVUS. Core Lab analyzes of all IVUS data.

4 Vessel Size Remodeling.

5 Positive Remodeling: large plaque mass. plaque is soft. more likely to have thrombus. associated with higher CRP. More common in young people. Very common in acute coronary syndrome. More common no reflow during PCI. Negative Remodeling: less plaque mass plaques are fibrotic. less likely to have thrombus.

6 Erosion Stable Thin cap atheroma Plaque hemorrhage Acute rupture Healed rupture Total occlusion IEL-Expected IEL (/plaque area) Remodeling in Varying Coronary Lesion Morphologies Macrophage infiltration Posit Remodeling A NC Medial SMC loss SMC loss Medial SMC apoptosis Virmani 2009

7 Cardiac CT can be as good as IVUS to detect Positive Remodeling

8 Positive Remodeling and Plaque Composition by OCT. Raffel et al. EHJ 2008;29:1721-8

9 Positive Remodeling and ISRS Okura et al. JACC 2001, 37: n= 108 BMS Positive Remodeling Intermed. or Negative Remodeling

10 Plaque Burden and In-Stent Intimal Hyperplasia WHC: Shiran et al, AJC 2000; 86: Maximal IH at 6 months angio was at the zone of maximal pre intervention plaque. Pre-intervention plaque area was an independent predictor of IH at follow up.

11 Remodeling and ISRS in DES. Mintz, Park et al. Circulation. 2003;108: ASPECT (ASian Paclitaxel-Eluting Stent Clinical Trial) positive intermed negative Cypher RS 28.6% vs 16.7% for positive and non posit remodeling p=ns. AHA 2009

12 Mild LMCA Disease and Remodeling. WHC: YJ Hong et al. JIC 2007;19: patients with mild (<50%) LMCA stenosis by angiography 1 year MACE

13 Positive Remodeling and Outcome in ACS. Okura, Mintz et al. AJC 2009;103:791-5

14 Prospect. MACE in Non Culprit Lesions

15 Attenuated Plaque (Black Holes, Echo Signal Attenuation) WHC: SY Lee, Mintz et al. JACC Interv 2009;2:65-72 Shadowing in spite of no visible calcium Two attenuated plaques 6.4 mm apart were seen in this RCA.

16 Attenuated Plaque in ACS. WHC: SY Lee, Mintz et al. JACC Interv 2009;2: ACS patients: 26% with attenuated plaque ( 40% STEMI, 18% NSTEMI) Attenuated plaque in ACS patients was associated with: - positive remodeling and higher CRP, - more thrombus and complex lesion morphology, - more plaque burden and plaque rupture, - frequent no-reflow after PCI.

17 Echo Signal Attenuation (EA). Kimura et al. Circ CV Interv. 2009;2: patients. EA: 43.8% in ACS vs. 27.9% in Stable AP, p< EA had Positive Remodeling: 55% vs 23 % for lesions without EA. Histology after DCA: higher prevalence of lipid-rich plaque, macrophage infiltration, cholesterol clefts, thrombus, and microcalcification.

18 No Reflow in SVG s with ACS. WHC: YJ Hong et al. TCT 06

19 IVUS images of the same cross section of coronary artery at baseline (left) and follow-up (right). The presence of a large branch at 10 o clock and a smaller branch at 7 o clock confirms that the same matched cross section has been studied at the 2 time points. Plaque Regression by IVUS Tardif et al. AJC 2006;98:2327 Intense Lipid Therapy x 2 years in 432 lesions <50%. Baseline IVUS IVUS at 24 months

20 Change in in area (mm2) Change in area (mm2) Progression of Disease in SVG WHC: YJ Hong JACC 2009;53:

21 Summary Positive remodeling with large plaque burden is an important observation that determines clinical and PCI outcomes.

22 CALCIFIED LESIONS

23 Patient with Angina and LAD Perfusion Defect Simple PCI?

24 IVUS of LAD In view of IVUS findings Roto-DES or LIMA need to be chosen

25 Different Strategies based on IVUS findings Direct Stenting A 5 m m Roto-Stent B

26

27 Concealed Vessel Perforation

28

29

30 Most Perforations are Not Seen by Angio. Maehara et al. WHC ,000 IVUS reviewed 76 perforations found on IVUS. Angio: 21% totally normal 33% dissections 22% mild stenosis 24% perforation suspected 12 months Follow up 30% MACE

31 Virtual Histology (A) Pathological intimal thickening. (B) Thin-capped fibroatheroma. (C) Thick-capped fibroatheroma. (D) Fibrotic plaque. (E) Fibrocalcific plaque.

32 The PROSPECT Trial IVUS of culprit lesion + 2 non culprit vessels 700 pts with ACS QCA of entire coronary tree IVUS with Virtual histology Palpography (n=~350) Meds rec Aspirin Plavix 1yr Statin Repeat 30 days, 6 months F/U: 1 mo, 6 mo, 1 yr, 2 yr, 3-5 yrs MSCT Substudy N= Repeat imaging in pts with events

33 MACE (%) PROSPECT: MACE All 20.4% Culprit Lesion Non Culprit Les. 12.9% 11.6% 5 0 Number at risk Time in Years ALL CL related NCL related Indetermina Indeterminate 2.7%

34 Plaque Burden, VH and Outcomes MACE in non Culprit lesions A 70% plaque burden lesion by gray scale IVUS has a risk of 9.2% at three years A 70% plaque burden lesion defined as VH TCFA has an elevated risk of 15.3% at three years A 70% plaque burden lesion defined as PIT has a reduced risk of only 2.6% at three years VH Definitions in PROSPECT can swing the risk profile The same lesions by grayscale IVUS (Plaque Burden 70%) have dramatically different risk profiles when looking at VH

35 Dynamic Nature of Plaque by VH. Kubo, Maehara et al. JACC 2010;55: Stable Progressive ACTIVE

36 Stenting and Plaque by VH. Koenig, Margolis, Virmani, Klaus. Nature Clinical Practice ;4 Koenig, Margolis, Virmani, Klaus. Nature Clinical Practice ;4

37 Stent in AMI Darius Dudek. TCT % NC covered 50% NC uncovered 10% Distal segment Proximal segment

38 Plaque Healing after Stenting Kubo et al. Am Heart J. 2010;159: Necrotic Core in contact with stent before and after Stenting DES BMS

39 Conclusions Plaque characterization by IVUS allows for: Better PCI planning and execution. Better PCI outcome. Better prediction of near and long term outcome. Better delineation of need for optimal medical therapy for that lesion. Better understanding of Coronary Atherosclerosis.

40 The end

The PROSPECT Trial. A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively Identify Vulnerable Plaque

The PROSPECT Trial. A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively Identify Vulnerable Plaque The PROSPECT Trial Providing Regional Observations to Study Predictors of Events in the Coronary Tree A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively

More information

Cardiovascular Research Foundation and Columbia University Medical Center, New York.

Cardiovascular Research Foundation and Columbia University Medical Center, New York. Virtual Histology Intravascular Ultrasound Analysis of Non-culprit Attenuated Plaques Detected by Grayscale Intravascular Ultrasound in Patients with Acute Coronary Syndromes Xiaofan Wu, Akiko Maehara,

More information

Imaging Overview for Vulnerable Plaque: Data from IVUS Trial and An Introduction to VH-IVUS Imgaging

Imaging Overview for Vulnerable Plaque: Data from IVUS Trial and An Introduction to VH-IVUS Imgaging Imaging Overview for Vulnerable Plaque: Data from IVUS Trial and An Introduction to VH-IVUS Imgaging Gary S. Mintz,, MD Cardiovascular Research Foundation New York, NY Today, in reality, almost everything

More information

The PROSPECT Trial. A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively Identify Vulnerable Plaque

The PROSPECT Trial. A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively Identify Vulnerable Plaque The PROSPECT Trial Providing Regional Observations to Study Predictors of Events in the Coronary Tree A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively

More information

Assessment of Vulnerable Plaque by IVUS and VH-IVUS

Assessment of Vulnerable Plaque by IVUS and VH-IVUS Assessment of Vulnerable Plaque by IVUS and VH-IVUS Akiko Maehara, MD Director of Intravascular Imaging & Physiology Core Laboratories Associate Director of MRI/MDCT Core Laboratory Cardiovascular Research

More information

Imaging Atheroma The quest for the Vulnerable Plaque

Imaging Atheroma The quest for the Vulnerable Plaque Imaging Atheroma The quest for the Vulnerable Plaque P.J. de Feijter 1. Department of Cardiology 2. Department of Radiology Coronary Heart Disease Remains the Leading Cause of Death in the U.S, Causing

More information

2yrs 2-6yrs >6yrs BMS 0% 22% 42% DES 29% 41% Nakazawa et al. J Am Coll Cardiol 2011;57:

2yrs 2-6yrs >6yrs BMS 0% 22% 42% DES 29% 41% Nakazawa et al. J Am Coll Cardiol 2011;57: Pathology of In-stent Neoatherosclerosis in BMS and DES 197 BMS, 103 SES, and 106 PES with implant duration >30 days The incidence of neoatherosclerosis was significantly greater in DES (31%) than BMS

More information

OCT Findings: Lesson from Stable vs Unstable Plaques

OCT Findings: Lesson from Stable vs Unstable Plaques ANGIOPLASTY SUMMIT TCTAP 2010 Imaging Workshop OCT Findings: Lesson from Stable vs Unstable Plaques Giulio Guagliumi MD Ospedali Riuniti di Bergamo, Italy DISCLOSURE OF FINANCIAL INTERESTS Consultant Boston

More information

Pathology of Vulnerable Plaque Angioplasty Summit 2005 TCT Asia Pacific, Seoul, April 28-30, 2005

Pathology of Vulnerable Plaque Angioplasty Summit 2005 TCT Asia Pacific, Seoul, April 28-30, 2005 Pathology of Vulnerable Plaque Angioplasty Summit 25 TCT Asia Pacific, Seoul, April 28-3, 25 Renu Virmani, MD CVPath, A Research Service of the International Registry of Pathology Gaithersburg, MD Plaque

More information

Optical Coherence Tomography for Intracoronary Imaging

Optical Coherence Tomography for Intracoronary Imaging Optical Coherence Tomography for Intracoronary Imaging Lorenz Räber Stephan Windecker Department of Cardiology Swiss Cardiovascular Center and Clinical Trials Unit Bern Bern University Hospital, Switzerland

More information

OCT; Comparative Imaging Results with IVUS, VH and Angioscopy

OCT; Comparative Imaging Results with IVUS, VH and Angioscopy OCT; Comparative Imaging Results with IVUS, VH and Angioscopy Takashi Akasaka, M.D. Department of Cardiovascular Medicine Wakayama, Japan Comparison among coronary imaging techniques OCT IVUS MRI CAG Angioscopy

More information

Plaque Characteristics in Coronary Artery Disease. Chourmouzios Arampatzis MD, PhD, FESC

Plaque Characteristics in Coronary Artery Disease. Chourmouzios Arampatzis MD, PhD, FESC Plaque Characteristics in Coronary Artery Disease Chourmouzios Arampatzis MD, PhD, FESC Disclosure Statement of Financial Interest Regarding this Presentation NONE Atherosclerosis Model proposed by Stary

More information

Gary S. Mintz,, MD. IVUS Observations in Acute (vs Chronic) Coronary Artery Disease: Structure vs Function

Gary S. Mintz,, MD. IVUS Observations in Acute (vs Chronic) Coronary Artery Disease: Structure vs Function Gary S. Mintz,, MD IVUS Observations in Acute (vs Chronic) Coronary Artery Disease: Structure vs Function Important IVUS Observations: Remodeling Originally used (first by Glagov) ) to explain atherosclerosis

More information

Invasive Coronary Imaging Modalities for Vulnerable Plaque Detection

Invasive Coronary Imaging Modalities for Vulnerable Plaque Detection Invasive Coronary Imaging Modalities for Vulnerable Plaque Detection Gary S. Mintz, MD Cardiovascular Research Foundation New York, NY Greyscale IVUS studies have shown Plaque ruptures do not occur randomly

More information

Left main coronary artery (LMCA): The proximal segment

Left main coronary artery (LMCA): The proximal segment Anatomy and Pathology of Left main coronary artery G Nakazawa Tokai Univ. Kanagawa, Japan 1 Anatomy Difinition Left main coronary artery (LMCA): The proximal segment RCA AV LAD LM LCX of the left coronary

More information

Intracoronary Imaging For Complex PCI A Pichard, L Satler, Ron Waksman, I Ben-Dor, W Suddath, N Bernardo, D Harrington.

Intracoronary Imaging For Complex PCI A Pichard, L Satler, Ron Waksman, I Ben-Dor, W Suddath, N Bernardo, D Harrington. Intracoronary Imaging For Complex PCI A Pichard, L Satler, Ron Waksman, I Ben-Dor, W Suddath, N Bernardo, D Harrington. Medstar Washington Hospital Center Washington, DC Conflict of Interest None for this

More information

Added Value of Invasive Coronary Imaging for Plaque Rupture and Erosion

Added Value of Invasive Coronary Imaging for Plaque Rupture and Erosion Assessment of Coronary Plaque Rupture and Erosion Added Value of Invasive Coronary Imaging for Plaque Rupture and Erosion Yukio Ozaki, MD, PhD, FACC, FESC Cardiology Dept., Fujita Health Univ. Toyoake,

More information

1st Department of Cardiology, University of Athens, Hippokration Hospital, Athens, Greece

1st Department of Cardiology, University of Athens, Hippokration Hospital, Athens, Greece Konstantinos Toutouzas, Maria Riga, Antonios Karanasos, Eleftherios Tsiamis, Andreas Synetos, Maria Drakopoulou, Chrysoula Patsa, Georgia Triantafyllou, Aris Androulakis, Christodoulos Stefanadis 1st Department

More information

as a Mechanism of Stent Failure

as a Mechanism of Stent Failure In-Stent t Neoatherosclerosis e osc e os s as a Mechanism of Stent Failure Soo-Jin Kang MD., PhD. University of Ulsan College of Medicine, Heart Institute Asan Medical Center, Seoul, Korea Disclosure I

More information

Culprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome

Culprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome Culprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome Hiroyuki Okura*, MD; Nobuya Matsushita**,MD Kenji Shimeno**, MD; Hiroyuki Yamaghishi**, MD Iku Toda**,

More information

Usefulness of OCT during coronary intervention

Usefulness of OCT during coronary intervention Usefulness of OCT during coronary intervention Takashi Akasaka, M.D. Department of Cardiovascular Medicine Wakayama, Japan Predictors at 12 Months of Stent Thrombosis and Target Lesion Revascularization

More information

CLINICAL APPLICATIONS OF OPTICAL COHERENCE TOMOGRAPHY. Konstantina P. Bouki, FESC 2 nd Department of Cardiology General Hospital Of Nikea, Pireaus

CLINICAL APPLICATIONS OF OPTICAL COHERENCE TOMOGRAPHY. Konstantina P. Bouki, FESC 2 nd Department of Cardiology General Hospital Of Nikea, Pireaus CLINICAL APPLICATIONS OF OPTICAL COHERENCE TOMOGRAPHY Konstantina P. Bouki, FESC 2 nd Department of Cardiology General Hospital Of Nikea, Pireaus OPTICAL COHERENCE TOMOGRAPHY (OCT) IVUS and OCT IVUS OCT

More information

Can We Identify Vulnerable Patients & Vulnerable Plaque?

Can We Identify Vulnerable Patients & Vulnerable Plaque? Can We Identify Vulnerable Patients & Vulnerable Plaque? We Know Enough to Treat High-Risk Lesions? Takashi Akasaka, MD, PhD Department of Cardiovascular Medicine, Japan Disclosure Statement of Financial

More information

Assessment of plaque morphology by OCT in patients with ACS

Assessment of plaque morphology by OCT in patients with ACS Assessment of plaque morphology by OCT in patients with ACS Takashi Akasaka, M.D. Department of Cardiovascular Medicine Wakayama, Japan Unstable plaque Intima Lipid core Plaque rupture and coronary events

More information

Pathology of Coronary Artery Disease

Pathology of Coronary Artery Disease Pathology of Coronary Artery Disease Seth J. Kligerman, MD Pathology of Coronary Artery Disease Seth Kligerman, MD Assistant Professor Medical Director of MRI University of Maryland Department of Radiology

More information

Failure of positive. Recanalization and CTO formation. TCFA rupture with (fatal) thrombotic occlusion. TCFA Lipid pool

Failure of positive. Recanalization and CTO formation. TCFA rupture with (fatal) thrombotic occlusion. TCFA Lipid pool Vulnerable Plaque features on coronary CT Jin Ho Choi, MD, PhD Department of Internal Medicine, Emergency Medicine Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea IPS /

More information

Coronary Artery Thermography

Coronary Artery Thermography Coronary Artery Thermography The 10th Anniversary, Interventional Vascular Therapeutics Angioplasty Summit 2005 TCT Asia Pacific Christodoulos Stefanadis Professor of Cardiology Athens Medical School In

More information

Integrating IVUS, FFR, and Noninvasive Imaging to Optimize Outcomes. Gary S. Mintz, MD Cardiovascular Research Foundation

Integrating IVUS, FFR, and Noninvasive Imaging to Optimize Outcomes. Gary S. Mintz, MD Cardiovascular Research Foundation Integrating IVUS, FFR, and Noninvasive Imaging to Optimize Outcomes Gary S. Mintz, MD Cardiovascular Research Foundation COURAGE Nuclear Substudy (n=314) Death/MI according the residual ischemia (SPECT)

More information

IVUS Analysis. Myeong-Ki. Hong, MD, PhD. Cardiac Center, Asan Medical Center University of Ulsan College of Medicine, Seoul, Korea

IVUS Analysis. Myeong-Ki. Hong, MD, PhD. Cardiac Center, Asan Medical Center University of Ulsan College of Medicine, Seoul, Korea IVUS Analysis Myeong-Ki Hong, MD, PhD Cardiac Center, Asan Medical Center University of Ulsan College of Medicine, Seoul, Korea Intimal disease (plaque) is dense and will appear white Media is made of

More information

Invasive Imaging (IVUS, VH-IVUS, and OCT): How I Implement into My

Invasive Imaging (IVUS, VH-IVUS, and OCT): How I Implement into My Invasive Imaging (IVUS, VH-IVUS, and OCT): How I Implement into My Practice Gary S. Mintz, MD Cardiovascular Research Foundation Modalities FFR IVUS (with or without VH, imap, or IB-IVUS) OCT NIRS (with

More information

State of the Art. Advances in Cardiovascular Imaging. ESC Congres Stockholm September 1, 2010 Frank E. Rademakers, MD, PhD, FESC

State of the Art. Advances in Cardiovascular Imaging. ESC Congres Stockholm September 1, 2010 Frank E. Rademakers, MD, PhD, FESC State of the Art Advances in Cardiovascular Imaging ESC Congres Stockholm September 1, 2010 Frank E. Rademakers, MD, PhD, FESC Coronary Artery Disease Content Patho Physiology Imaging requirements Economical

More information

Strategies for PCI of SVG

Strategies for PCI of SVG Strategies for PCI of SVG Ron Waksman, MD, FACC Augusto Pichard, MD, FACC Washington Hospital Center, Washington DC OPTIONS FOR IMPROVED OUTCOMES IN SVG PCI Direct Stenting Thrombus Management Embolic

More information

대한심장학회춘계학술대회 Satellite Symposium

대한심장학회춘계학술대회 Satellite Symposium 대한심장학회춘계학술대회 Satellite Symposium Coronary Plaque Regression and Compositional Changes by Lipid-Lowering Therapy: IVUS Substudy in Livalo (Pitavastatin) in Acute Myocardial Infarction Study (LAMIS) Livalo

More information

Vulnerable Plaque Pathophysiology, Detection, and Intervention. VP: A Local Problem or Systemic Disease. Erling Falk, Denmark

Vulnerable Plaque Pathophysiology, Detection, and Intervention. VP: A Local Problem or Systemic Disease. Erling Falk, Denmark Vulnerable Plaque Pathophysiology, Detection, and Intervention VP: A Local Problem or Systemic Disease Erling Falk, Denmark Vulnerable Plaque Pathophysiology, Detection, and Intervention VP: A Local Problem

More information

Assessment of vulnerable plaque by OCT

Assessment of vulnerable plaque by OCT Assessment of vulnerable plaque by OCT Comparison with histology and possible clinical applications Takashi Akasaka, M.D. Department of Cardiovascular Medicine Wakayama, Japan Identification of vulnerable

More information

Clinical Value of OCT. Guidance for Coronary Stenting. Giulio Guagliumi, MD

Clinical Value of OCT. Guidance for Coronary Stenting. Giulio Guagliumi, MD Clinical Value of OCT Guidance for Coronary Stenting Giulio Guagliumi, MD 100 % Endovascular Imaging Indications of use 87.5 % 75 % 57.5 % 50 % 45 % 25 % 15 % 0 Lesion morphology Stent optimization Lesion

More information

Insights in Thrombosis and In-Stent Restenosis

Insights in Thrombosis and In-Stent Restenosis Clinical Value of OCT Insights in Thrombosis and In-Stent Restenosis Fernando Alfonso MD, PhD, FESC Interventional Cardiology. Cardiovascular Institute. Clinico San Carlos University Hospital. Madrid.

More information

High-risk vulnerable plaques. Kostis Raisakis G.Gennimatas General Hospital of Athens

High-risk vulnerable plaques. Kostis Raisakis G.Gennimatas General Hospital of Athens High-risk vulnerable plaques. Kostis Raisakis G.Gennimatas General Hospital of Athens Overview: 1 Definition-Pathology 2 3 Diagnostic Strategies Invasive Non Invasive Prognostic Value of Detection 4 Treatment

More information

IVUS vs FFR Debate: IVUS-Guided PCI

IVUS vs FFR Debate: IVUS-Guided PCI IVUS vs FFR Debate: IVUS-Guided PCI Gary S. Mintz, MD Cardiovascular Research Foundation New York, NY Disclosure Statement of Financial Interest Within the past 12 months, I have had a financial interest/arrangement

More information

CASE from South Korea

CASE from South Korea CASE from South Korea Bon-Kwon Koo, MD, PhD, Seoul, Korea Outpatient clinic of a non-interventional cardiologist F/56 Chief complaint: Angina with recent aggravation, CCS II~III Brief history: # Stroke

More information

Cottrell Memorial Lecture. Has Reversing Atherosclerosis Become the New Gold Standard in the Treatment of Cardiovascular Disease?

Cottrell Memorial Lecture. Has Reversing Atherosclerosis Become the New Gold Standard in the Treatment of Cardiovascular Disease? Cottrell Memorial Lecture Has Reversing Atherosclerosis Become the New Gold Standard in the Treatment of Cardiovascular Disease? Stephen Nicholls MBBS PhD @SAHMRI_Heart Disclosures Research support: AstraZeneca,

More information

Between Coronary Angiography and Fractional Flow Reserve

Between Coronary Angiography and Fractional Flow Reserve Visual-Functional Mismatch Between Coronary Angiography and Fractional Flow Reserve Seung-Jung Park, MD., PhD. University of Ulsan, College of Medicine Asan Medical Center, Seoul, Korea Visual - Functional

More information

FESC, FACC, MAHA, MSCAI, MEAPSI, ESH

FESC, FACC, MAHA, MSCAI, MEAPSI, ESH «Απεικόνιση και φυσιολογία στο αιμοδυναμικό εργαστήριο». Eυάλωτη αθηρωματική πλάκα. Πού βρισκόμαστε? Ηλίας Α. Σανίδας MD, PhD, FESC, FACC, MAHA, MSCAI, MEAPSI, ESH Specialist Επεμβατικός Kαρδιολόγος Επιμελητής,

More information

Que nos puede aportar el OCT intracoronario

Que nos puede aportar el OCT intracoronario XXXI Jornadas SOLACI. 10ª Región CONOSUR LIIIº Congreso Chileno de Cardiología y Cirugía Cardiovascular Hotel Patagónico. Puerto Varas. Chile (30 Nov 1 Dic 2016) Que nos puede aportar el OCT intracoronario

More information

Cardiac CT Angiography

Cardiac CT Angiography Cardiac CT Angiography Dr James Chafey, Radiologist Why do we need a better test for C.A.D? 1. CAD is the leading cause of death in the US CAD 31% Cancer 23% Stroke 7% 2. The prevalence of atherosclerosis

More information

Κλινική Χρήση IVUS και OCT PERIKLIS A. DAVLOUROS ASSOCIATE PROFESSOR OF CARDIOLOGY INVASIVE CARDIOLOGY & CONGENITAL HEART DISEASE

Κλινική Χρήση IVUS και OCT PERIKLIS A. DAVLOUROS ASSOCIATE PROFESSOR OF CARDIOLOGY INVASIVE CARDIOLOGY & CONGENITAL HEART DISEASE Κλινική Χρήση IVUS και OCT PERIKLIS A. DAVLOUROS ASSOCIATE PROFESSOR OF CARDIOLOGY INVASIVE CARDIOLOGY & CONGENITAL HEART DISEASE Conflict of interest None to declare While IVUS is the most used intravascular

More information

ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions

ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions Julinda Mehilli, MD Deutsches Herzzentrum Technische Universität Munich Germany ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions Background Left main

More information

Catch-up Phenomenon: Insights from Pathology

Catch-up Phenomenon: Insights from Pathology Catch-up Phenomenon: Insights from Pathology Michael Joner, MD CVPath Institute Inc. Gaithersburg, MD USA Path Lessons learned from the BMS and DES (1 st Gen) era Neointimal Thickness [mm] In Stent Re

More information

Percutaneous Intervention of Unprotected Left Main Disease

Percutaneous Intervention of Unprotected Left Main Disease Percutaneous Intervention of Unprotected Left Main Disease Technical feasibility and Clinical outcomes Seung-Jung Park, MD, PhD, FACC Professor of Internal Medicine Asan Medical Center, Seoul, Korea Unprotected

More information

Invasive Evaluation of High Risk or Vulnerable Plaque A Powerful Tool to Address Potential Pharmacological Agents? Jagat Narula, MD PhD MACC

Invasive Evaluation of High Risk or Vulnerable Plaque A Powerful Tool to Address Potential Pharmacological Agents? Jagat Narula, MD PhD MACC Invasive Evaluation of High Risk or Vulnerable Plaque A Powerful Tool to Address Potential Pharmacological Agents? Jagat Narula, MD PhD MACC No Conflicts of Interest to Declare Histological Signatures

More information

EAE Teaching Course. Magnetic Resonance Imaging. Competitive or Complementary? Sofia, Bulgaria, 5-7 April F.E. Rademakers

EAE Teaching Course. Magnetic Resonance Imaging. Competitive or Complementary? Sofia, Bulgaria, 5-7 April F.E. Rademakers EAE Teaching Course Magnetic Resonance Imaging Competitive or Complementary? Sofia, Bulgaria, 5-7 April 2012 F.E. Rademakers Complementary? Of Course N Engl J Med 2012;366:54-63 Clinical relevance Treatment

More information

PCI for Long Coronary Lesion

PCI for Long Coronary Lesion PCI for Long Coronary Lesion Shift of a General Idea with the Introduction of DES In the Bare Metal Stent Era Higher Restenosis Rate With Increasing Stent Length and Decreasing Stent Area Restenosis.6.4.2

More information

Integrated Use of IVUS and FFR for LM Stenting

Integrated Use of IVUS and FFR for LM Stenting Integrated Use of IVUS and FFR for LM Stenting Gary S. Mintz, MD Cardiovascular Research Foundation Four studies have highlighted the inaccuracy of angiography in the assessment of LMCA disease Fisher

More information

Non-invasive Plaque Imaging

Non-invasive Plaque Imaging Characterization of Coronary Atherosclerotic Plaques Using CTA Koen Nieman, MD Erasmus University Medical Center Thoraxcenter, dept. of Cardiology Dept. of Radiology Rotterdam, The Netherlands Massachusetts

More information

OCT GUIDED TREATMENT OF CALCIFIED LESIONS RICHARD SHLOFMITZ, MD CHAIRMAN OF DEPT. OF CARDIOLOGY ST. FRANCIS HOSPITAL ROSLYN, NEW YORK

OCT GUIDED TREATMENT OF CALCIFIED LESIONS RICHARD SHLOFMITZ, MD CHAIRMAN OF DEPT. OF CARDIOLOGY ST. FRANCIS HOSPITAL ROSLYN, NEW YORK OCT GUIDED TREATMENT OF CALCIFIED LESIONS RICHARD SHLOFMITZ, MD CHAIRMAN OF DEPT. OF CARDIOLOGY ST. FRANCIS HOSPITAL ROSLYN, NEW YORK Disclosure Statement of Financial Interest Within the past 12 months,

More information

Sites of Atherosclerosis In order of Frequency

Sites of Atherosclerosis In order of Frequency Pathological Features of Peripheral Atherosclerosis: Implication for Device Development G Nakazawa Tokai Univ. Kanagawa, Japan 1 Sites of Atherosclerosis In order of Frequency carotid (3) (3) Coronary

More information

Intervention: How and to which extent is technology helping us?

Intervention: How and to which extent is technology helping us? Cardiological Society of India Congress 12th February 2016 Chennai, India Intervention: How and to which extent is technology helping us? SIMONE BISCAGLIA MD CARDIOVASCULAR INSTITUTE, FERRARA, ITALY Introduction

More information

A Novel Low Pressure Self Expanding Nitinol Coronary Stent (vprotect): Device Design and FIH Experience

A Novel Low Pressure Self Expanding Nitinol Coronary Stent (vprotect): Device Design and FIH Experience A Novel Low Pressure Self Expanding Nitinol Coronary Stent (vprotect): Device Design and FIH Experience Juan F. Granada, MD Medical Director, Skirball Center for Cardiovascular Research The Cardiovascular

More information

Defining Plaque Composition by CTA: The Latest Tool to Monitor Therapy?

Defining Plaque Composition by CTA: The Latest Tool to Monitor Therapy? Defining Plaque Composition by CTA: The Latest Tool to Monitor Therapy? John McB. Hodgson, M.D., FSCAI Chairman, Department of Cardiology Geisinger Health System Wilkes Barre,, Pa Disclosure Information

More information

Debate Should we use FFR? I will say NO.

Debate Should we use FFR? I will say NO. Debate Should we use FFR? I will say NO. Hyeon-Cheol Gwon Cardiac and Vascular Center Samsung Medical Center Sungkyunkwan University School of Medicine Dr. Hyeon-Cheol Gwon Research fund from Abbott Korea

More information

FFR= Qs/Qn. Ohm s law R= P/Q Q=P/R

FFR= Qs/Qn. Ohm s law R= P/Q Q=P/R 32 ο Πανελλήνιο Καρδιολογικό Συνζδριο, Θεσσαλονίκη 20/10/2011 Gould KL et al, JACC CARDIOVASC IMAG 2009 Gould KL et al AM J CARDIOL 1974 & JACC CARDIOVASC IMAG 2009 Under maximal hyperemia: Rs=Rn FFR=

More information

The Dynamic Nature of Coronary Artery Lesion Morphology Assessed by Serial Virtual Histology Intravascular Ultrasound Tissue Characterization

The Dynamic Nature of Coronary Artery Lesion Morphology Assessed by Serial Virtual Histology Intravascular Ultrasound Tissue Characterization Journal of the American College of Cardiology Vol. 55, No. 15, 2010 2010 by the American College of Cardiology Foundation ISSN 0735-1097/10/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2009.07.078

More information

Basics of Angiographic Interpretation Analysis of Angiography

Basics of Angiographic Interpretation Analysis of Angiography Basics of Angiographic Interpretation Analysis of Angiography Young-Hak Kim, MD, PhD Cardiac Center, University of Ulsan College of Medicine, Seoul, Korea What made us nervous Supervisors Stent Contrast

More information

Optimal assessment observation of intravascular ultrasound

Optimal assessment observation of intravascular ultrasound Optimal assessment observation of intravascular ultrasound Katsutoshi Kawamura and Atsunori Okamura Division of Radiology Cardiovascular Center Sakurabashi Watanabe Hospital SAKURABASHI WATANABE Hospital

More information

The Future of intravascular Is there light or sound at the end of the tunnel? Hybrid Imaging

The Future of intravascular Is there light or sound at the end of the tunnel? Hybrid Imaging The Future of intravascular imaging : Is there light or sound at the end of the tunnel? Hybrid Imaging Jung Ho Heo MD, PhD Kosin University Hospital Busan, Korea From: A Heart With 67 Stents J Am Coll

More information

Dynamic Nature of Nonculprit Coronary Artery Lesion Morphology in STEMI

Dynamic Nature of Nonculprit Coronary Artery Lesion Morphology in STEMI JACC: CARDIOVASCULAR IMAGING VOL. 6, NO. 1, 2013 2013 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 1936-878X/$36.00 PUBLISHED BY ELSEVIER INC. http://dx.doi.org/10.1016/j.jcmg.2012.08.010 Dynamic

More information

New Insight about FFR and IVUS MLA

New Insight about FFR and IVUS MLA New Insight about FFR and IVUS MLA Can IVUS MLA Predict FFR

More information

PCI for In-Stent Restenosis. CardioVascular Research Foundation

PCI for In-Stent Restenosis. CardioVascular Research Foundation PCI for In-Stent Restenosis ISR of BMS Patterns of In-Stent Restenosis Pattern I : Focal Type IA: Articulation / Gap Type IB: Marginal Type IC: Focal body Type ID: Multifocal Pattern II,III,IV : Diffuse

More information

Noninvasive Coronary Imaging: Plaque Imaging by MDCT

Noninvasive Coronary Imaging: Plaque Imaging by MDCT Coronary Physiology & Imaging Summit 2007 Noninvasive Coronary Imaging: Plaque Imaging by MDCT Byoung Wook Choi Department of Radiology Yonsei University, Seoul, Korea Stary, H. C. et al. Circulation

More information

Chapter 43 Noninvasive Coronary Plaque Imaging

Chapter 43 Noninvasive Coronary Plaque Imaging hapter 43 Noninvasive oronary Plaque Imaging NIRUDH KOHLI The goal of coronary imaging is to define the extent of luminal narrowing as well as composition of an atherosclerotic plaque to facilitate appropriate

More information

FFR-guided Jailed Side Branch Intervention

FFR-guided Jailed Side Branch Intervention FFR-guided Jailed Side Branch Intervention - Pressure wire in Bifurcation lesions - Bon-Kwon Koo, MD, PhD Seoul National University Hospital, Seoul, Korea Bifurcation Lesions Bifurcation Lesions Still

More information

Unprotected LM intervention

Unprotected LM intervention Unprotected LM intervention Guideline for COMBAT Seung-Jung Park, MD, PhD Professor of Internal Medicine, Seoul, Korea Current Recommendation for unprotected LMCA Stenosis Class IIb C in ESC guideline

More information

What is the Optimal Triple Anti-platelet Therapy Duration in Patients with Acute Myocardial Infarction Undergoing Drug-eluting Stents Implantation?

What is the Optimal Triple Anti-platelet Therapy Duration in Patients with Acute Myocardial Infarction Undergoing Drug-eluting Stents Implantation? What is the Optimal Triple Anti-platelet Therapy Duration in Patients with Acute Myocardial Infarction Undergoing Drug-eluting Stents Implantation? Keun-Ho Park, Myung Ho Jeong, Min Goo Lee, Jum Suk Ko,

More information

Role of Intravascular Ultrasound in Patients with Acute Myocardial Infarction

Role of Intravascular Ultrasound in Patients with Acute Myocardial Infarction Review Article Print ISSN 1738-5520 On-line ISSN 1738-5555 Korean Circulation Journal Role of Intravascular Ultrasound in Patients with Acute Myocardial Infarction Young Joon Hong, MD, Youngkeun Ahn, MD,

More information

Malaysian Healthy Ageing Society

Malaysian Healthy Ageing Society Organised by: Co-Sponsored: Malaysian Healthy Ageing Society CAD INVESTIGATIONS PHYSIOLOGICAL / FUNCTIONAL VS ANATOMICAL / STRUCTURAL Disclosure iheal medical centre is a one stop cardiac centre with

More information

IN-STENT RESTENOSIS. K.Boerlage-van Dijk CarVasZ 2014

IN-STENT RESTENOSIS. K.Boerlage-van Dijk CarVasZ 2014 IN-STENT RESTENOSIS K.Boerlage-van Dijk CarVasZ 2014 Definition ISR Angiographic: recurrent diameter stenosis >50% at the stent segment or edges (5-mm segments adjacent to stent) Mehran system morphological

More information

CPIS So-Yeon Choi, MD., PhD. Department of Cardiology Ajou University School of MedicineSuwon, Korea

CPIS So-Yeon Choi, MD., PhD. Department of Cardiology Ajou University School of MedicineSuwon, Korea So-Yeon Choi, MD., PhD. Department of Cardiology Ajou University School of MedicineSuwon, Korea Coronary Artery Imaging The ideal coronary imaging technology would be capable of identifying not only vessel

More information

CT Imaging of Atherosclerotic Plaque. William Stanford MD Professor-Emeritus Radiology University of Iowa College of Medicine Iowa City, IA

CT Imaging of Atherosclerotic Plaque. William Stanford MD Professor-Emeritus Radiology University of Iowa College of Medicine Iowa City, IA CT Imaging of Atherosclerotic Plaque William Stanford MD Professor-Emeritus Radiology University of Iowa College of Medicine Iowa City, IA PREVALENCE OF CARDIOVASCULAR DISEASE In 2006 there were 80 million

More information

What Stent to Use? JASVINDAR SINGH MD, FACC

What Stent to Use? JASVINDAR SINGH MD, FACC What Stent to Use? JASVINDAR SINGH MD, FACC ASSOCIATE PROFESSOR OF MEDICINE WASHINGTON UNIVERSITY IN ST. LOUIS DIRECTOR, CARDIAC CATHETERIZATION LAB BARNES-JEWISH HOSPITAL What Stent to Use? Jasvindar

More information

Quick guide. Core. precision guided therapy system

Quick guide. Core. precision guided therapy system Quick guide Core precision guided therapy system The Philips Volcano imaging system should only be operated by trained personnel. The following information is presented for your convenience and is not

More information

Smooth muscle pharmacology & interventional cardiology

Smooth muscle pharmacology & interventional cardiology Smooth muscle pharmacology & interventional cardiology By: Pascal Bernatchez!!!!! LAST LECTURE Classic Vascular pharmacology -chronic -systemic Local Vascular pharmacology -acute -targeted High blood pressure

More information

Quinn Capers, IV, MD

Quinn Capers, IV, MD Heart Attacks Mended Hearts Presentation, January, 2017 Quinn Capers, IV, MD Associate Professor of Medicine (Cardiovascular Medicine) Director, Transradial Coronary Interventions Division of Cardiovascular

More information

LM stenting - Cypher

LM stenting - Cypher LM stenting - Cypher Left main stenting with BMS Since 1995 Issues in BMS era AMC Restenosis and TLR (%) 3 27 TLR P=.282 Restenosis P=.71 28 2 1 15 12 Ostium 5 4 Shaft Bifurcation Left main stenting with

More information

PCI for Bifurcation Coronary Lesion

PCI for Bifurcation Coronary Lesion PCI for Bifurcation Coronary Lesion Bifurcation Lesions PCI is Challenging Higher acute complication Lower success rates Higher restenosis & TLR Restenosis Rate 21 ~ 57% TLR 8 ~ 43% Event Free Survival

More information

Left Main PCI. Integrated Use of IVUS and FFR. Seung-Jung Park, MD, PhD

Left Main PCI. Integrated Use of IVUS and FFR. Seung-Jung Park, MD, PhD Left Main PCI Integrated Use of IVUS and FFR Seung-Jung Park, MD, PhD Professor of Medicine, University of Ulsan College of Medicine, Heart Institute, Asan Medical Center, Seoul, Korea Efficacy of Left

More information

Evaluation of Intermediate Coronary lesions: Can You Handle the Pressure? Jeffrey A Southard, MD May 4, 2013

Evaluation of Intermediate Coronary lesions: Can You Handle the Pressure? Jeffrey A Southard, MD May 4, 2013 Evaluation of Intermediate Coronary lesions: Can You Handle the Pressure? Jeffrey A Southard, MD May 4, 2013 Disclosures Consultant- St Jude Medical Boston Scientific Speaker- Volcano Corporation Heart

More information

RESTENOSIS Facing up to the problem

RESTENOSIS Facing up to the problem RESTENOSIS Facing up to the problem Petr Kala University Hospital Brno Czech Republic ESC 2011, Paris Disclosure Scientific Advisory Boards or Education presentations fee Abbott, Boston Scientific, Cordis

More information

ROLE OF CORONARY PRESSURE & FFR IN MULTIVESSEL DISEASE

ROLE OF CORONARY PRESSURE & FFR IN MULTIVESSEL DISEASE ROLE OF CORONARY PRESSURE & FFR IN MULTIVESSEL DISEASE Angioplasty Summit TCT ASIA Seoul, Korea, april 24th, 2008 Nico H. J. Pijls, MD, PhD Catharina Hospital, Eindhoven, The Netherlands A rather common

More information

IVUS Assessment of the Mechanism of In-stent Restenosis? Gary S. Mintz, MD Cardiovascular Research Foundation

IVUS Assessment of the Mechanism of In-stent Restenosis? Gary S. Mintz, MD Cardiovascular Research Foundation IVUS Assessment of the Mechanism of In-stent Restenosis? Gary S. Mintz, MD Cardiovascular Research Foundation SURE Trial: Restenosis in non-stented lesions Average of the two image slices with the smallest

More information

Evaluation COMBO s Healing Profile The EGO-COMBO Serial OCT Study

Evaluation COMBO s Healing Profile The EGO-COMBO Serial OCT Study Evaluation COMBO s Healing Profile The EGO-COMBO Serial OCT Study OrbusNeich Dual Therapy COMBO Stent Symposium 25 th April 2013 Prof. Stephen WL Lee, JP 李偉聯 MD FRCP(Lon. Edin. Glas.) FHKCP FHKAM FACC

More information

In-Stent Restenosis. Can we kill it?

In-Stent Restenosis. Can we kill it? In-Stent Restenosis Can we kill it? However, In-stent Restenosis is the most serious problem (2-25%) More than 15, lesions will need treatment because of in-stent restenosis. Varying Prevalence Rates of

More information

Controversies in Coronary Revascularization. Atlanta CCU April 15, 2016

Controversies in Coronary Revascularization. Atlanta CCU April 15, 2016 Controversies in Coronary Revascularization Atlanta CCU April 15, 2016 Habib Samady MD FACC FSCAI Professor of Medicine Director, Interventional Cardiology, Emory University Director, Cardiac Catheterization

More information

PCI for Left Anterior Descending Artery Ostial Stenosis

PCI for Left Anterior Descending Artery Ostial Stenosis PCI for Left Anterior Descending Artery Ostial Stenosis Why do you hesitate PCI for LAD ostial stenosis? LAD Ostial Lesion Limitations of PCI High elastic recoil Involvement of the distal left main coronary

More information

From the Vulnerable Atherosclerotic Plaque to CAD Management

From the Vulnerable Atherosclerotic Plaque to CAD Management 33 rd Panhellenic Congress of Cardiology Athens, November 1-3, 2012 From the Vulnerable Atherosclerotic Plaque to CAD Management Filippos Triposkiadis, MD, FESC, FACC Professor of Cardiology Director,

More information

DES In-stent Restenosis

DES In-stent Restenosis DES In-stent Restenosis Roxana Mehran, MD Columbia University Medical Center The Cardiovascular Research Foundation DES Restenosis Mechanisms Predictors Morphological patterns Therapy approach Mechanisms

More information

Review Article Optical Coherence Tomography Imaging in Acute Coronary Syndromes

Review Article Optical Coherence Tomography Imaging in Acute Coronary Syndromes SAGE-Hindawi Access to Research Cardiology Research and Practice Volume 2011, Article ID 312978, 7 pages doi:10.4061/2011/312978 Review Article Optical Coherence Tomography Imaging in Acute Coronary Syndromes

More information

Fielder XT: Initial and. Department of Cardiology, Asan Medical Center, Ulsan University of college of medicine

Fielder XT: Initial and. Department of Cardiology, Asan Medical Center, Ulsan University of college of medicine Fielder XT: Initial and Professional Use for CTO Seung-Whan Lee, MD, PhD D t t f C di l A M di l C t Department of Cardiology, Asan Medical Center, Ulsan University of college of medicine Plastic-Jacket

More information

Potential recommendations for CT coronary angiography in athletes

Potential recommendations for CT coronary angiography in athletes Potential recommendations for CT coronary angiography in athletes B.K. Velthuis Dept. of Radiology UMC Utrecht, the Netherlands EuroPRevent 15 April 2011 Declaration of interest Philips Medical Systems

More information

IVUS Virtual Histology. Listening through Walls D. Geoffrey Vince, PhD The Cleveland Clinic Foundation

IVUS Virtual Histology. Listening through Walls D. Geoffrey Vince, PhD The Cleveland Clinic Foundation IVUS Virtual Histology Listening through Walls D. Geoffrey Vince, PhD Disclosure VH is licenced to Volcano Therapeutics Grant funding from Pfizer, Inc. Grant funding from Boston-Scientific Most Myocardial

More information

Jose Mª de la Torre Hernandez, MD, PhD, FESC. Cardiologia Valdecilla Hospital Universitario Marques de Valdecilla Santander. SPAIN

Jose Mª de la Torre Hernandez, MD, PhD, FESC. Cardiologia Valdecilla Hospital Universitario Marques de Valdecilla Santander. SPAIN Validation and application of IVUS-MLA in LMCA disease Jose Mª de la Torre Hernandez, MD, PhD, FESC Interventional Cardiology Dpt Cardiologia Valdecilla Hospital Universitario Marques de Valdecilla Santander.

More information